Literature DB >> 12689907

Inferior conjunctival autograft for primary pterygia.

Padmanabha Pillai Syam1, Haralabos Eleftheriadis, Christopher S C Liu.   

Abstract

OBJECTIVE: Superior conjunctival graft is commonly used in pterygium surgery, which may adversely affect the outcome of future filtration surgery. We retrospectively studied the success rate of inferior conjunctival autografting for primary pterygia in our unit.
DESIGN: A noncomparative, retrospective, interventional case series. PARTICIPANTS: Thirty eyes of 27 patients treated between August 1996 and February 2001 with primary pterygia. INTERVENTION: Excision of pterygium followed by conjunctival autograft harvested from the inferior bulbar conjunctiva. Surgeries were performed by an experienced surgeon (CL) in 23 patients and by trainees in the remaining four cases. MAIN OUTCOME MEASURES: Recurrence of the pterygium and complications.
RESULTS: Mean follow-up was 27 months (range, 8-53). Recurrence occurred in one eye (3.3%). This was a white female in her early fifties, with recurrence detected 3 months after the surgery. Conjunctival scarring at the donor site was observed in 11 eyes (36.66%). There was no symblepharon formation. There was no restriction of up gaze. Hemorrhage under the conjunctival graft developed in three eyes, corneal dellen near the limbus developed in four eyes, and epithelial inclusion cysts at the recipient site developed in two eyes.
CONCLUSIONS: Inferior conjunctival autografting is an effective technique with a low recurrence rate. This is a useful technique in cases in which it is not possible or desirable to use the superior conjunctiva as a donor source.

Entities:  

Mesh:

Year:  2003        PMID: 12689907     DOI: 10.1016/S0161-6420(02)01970-X

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Safety and efficacy of pterygium extended removal followed by extended conjunctival transplant for recurrent pterygia.

Authors:  Waleed A Allam; Ahmed Roshdy Alagorie; Mohammed H Nasef; Molham A El-Bakary
Journal:  Int Ophthalmol       Date:  2022-01-03       Impact factor: 2.029

2.  Comparing techniques for pterygium surgery.

Authors:  Atilla Alpay; Suat Hayri Uğurbaş; Berktuğ Erdoğan
Journal:  Clin Ophthalmol       Date:  2009-06-02

3.  Inferior conjunctival autografting for pterygium surgery: an alternative way of preserving the glaucoma filtration site in far western Nepal.

Authors:  Arjun Shrestha; Anand Shrestha; Sujata Bhandari; Nhukesh Maharjan; Deepak Khadka; Suresh Raj Pant; Bidya Prasad Pant
Journal:  Clin Ophthalmol       Date:  2012-03-01

4.  Separate limbal-conjunctival autograft transplantation using the inferior conjunctiva for primary pterygium.

Authors:  Hiroki Kawano; Koji Kawano; Taiji Sakamoto
Journal:  Oman J Ophthalmol       Date:  2011-09

Review 5.  How to minimize pterygium recurrence rates: clinical perspectives.

Authors:  Raffaele Nuzzi; Federico Tridico
Journal:  Clin Ophthalmol       Date:  2018-11-19

6.  Recurrence rate with inferior conjunctival autograft transplantation compared with superior conjunctival autograft transplantation in pterygium surgery: a meta-analysis.

Authors:  Wenwei Li; Yaoyong Lou; Bin Wang
Journal:  BMC Ophthalmol       Date:  2021-03-09       Impact factor: 2.209

Review 7.  The use of dry amniotic membrane in pterygium surgery.

Authors:  Gelareh S Noureddin; Sonia N Yeung
Journal:  Clin Ophthalmol       Date:  2016-04-18

8.  Comparison of hyperdry amniotic membrane transplantation and conjunctival autografting for primary pterygium.

Authors:  Xin Pan; Daguang Zhang; Zhifang Jia; Zhehui Chen; Yuetian Su
Journal:  BMC Ophthalmol       Date:  2018-05-15       Impact factor: 2.209

9.  Comparison of inferior conjunctival autografting and conjunctival tissue grafting from pterygium itself in the cases of filtering blebs and glaucoma suspects-A retrospective analysis.

Authors:  Shreesha Kumar Kodavoor; B Soundarya; Ramamurthy Dandapani
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.